-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Panzhihua Iron and Steel Vanadium Titanium (000629.
SZ) released the 2021 annual performance forecast.
It is estimated that the annual net profit attributable to shareholders of the listed company is 1.
28 billion yuan to 1.
38 billion yuan, an increase of 236.
03%-262.
29% over the same period of the previous year (adjusted)
.
Net profit after deducting non-recurring gains and losses was 1.
28 billion-1.
38 billion yuan, an increase of 246.
40%-273.
47% over the same period of the previous year (adjusted)
.
It is estimated that the net profit attributable to shareholders of listed companies in 2021 will increase by 236.
03% to 262.
29% compared with the same period of the previous year (after adjustment), the main reason is: the company's shareholders meeting reviewed and approved on September 29, 2021.
The Proposal of 100% Equity and Related Transactions of Xichang Vanadium Products Technology Co.
, Ltd.
of Steel Group", as of October 15, 2021, the acquisition has been completed
.
According to the agreement signed by the two parties, on October 1, 2021, Xichang Vanadium Products has been included in the company's consolidated financial statements.
According to the "Accounting Standards for Business Enterprises-No.
33 Consolidated Financial Statements", "business mergers under the same control increase subsidiaries or businesses, and prepare a consolidated income statement.
At the time of merger, the income, expenses and profits of the subsidiary or business from the beginning of the merger period to the end of the reporting period should be included in the consolidated income statement, rather than included in the consolidated income statement from the merger date, and adjustments should be made to the relevant items in the comparative statement.
The data of this reporting period includes the amount of Xichang vanadium products from the beginning of the reporting period to the end of the reporting period, and the data of 2020 for the same period of the previous year will be consolidated with the same caliber in the comparative analysis of the data of Xichang vanadium products;
